PharmaShots | Incisive News in 3 Shots

Subscribe Now

Hodgkin Lymphoma

BeiGene Reports Updated Results of Tislelizumab in P-II Study in Chinese Patients with R/R Classical Hodgkin Lymphoma #EHA2019

BeiGene Reports Updated Results of Tislelizumab in P-II Study in Chinese Patients with R/R Classical Hodgkin Lymphoma #EHA2019

June 14, 2019

Takeda's Adcetris (brentuximab vedotin) + AVD Receives EU Approval for CD30+ Stage IV Hodgkin Lymphoma (HL) in Adults

Takeda's Adcetris (brentuximab vedotin) + AVD Receives EU Approval for CD30+ Stage IV Hodgkin Lymphoma (HL) in Adults

February 12, 2019

Seattle Genetics Reports Multiple Results of Adcetris (Brentuximab Vedotin) in P-III ECHELON-1- P-I/II- P-II and P-III AETHERA study in Patients with Hodgkin Lymphoma at ISHL 2018

Seattle Genetics Reports Multiple Results of Adcetris (Brentuximab Vedotin) in P-III ECHELON-1- P-I/II- P-II and P-III AETHERA stu...

October 26, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us